SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes inspection at Unichem Laboratories’ Kolhapur API facility

03 Feb 2026 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at the Unichem Laboratories’ Kolhapur API facility from January 27, 2026 to February 02, 2026.

The inspection closed with five observations which were more of procedural changes with none of these related to data integrity. The Company will provide the necessary response to USFDA within stipulated 15 days.

Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs).

Unichem Lab Share Price

337.10 -2.25 (-0.66%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×